Insomnia News and Research

Latest Insomnia News and Research

Orexo announces positive results from ISTART/006 study

Orexo US, Inc. announced results from the ISTART/006 study, being presented today at the 25th Annual Meeting and Symposium of the American Academy of Addiction Psychiatry in Aventura, Florida, USA.

7 Dec 2014

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its New Drug Applications (NDAs) for two dosages of abacavir/lamivudine tablets for oral suspension for the treatment of HIV-1 infection in pediatric patients.

4 Dec 2014

MGH investigators develop system to accurately track the process of falling asleep

Massachusetts General Hospital investigators have developed a system to accurately track the dynamic process of falling asleep, something has not been possible with existing techniques. In their report in the October issue of the open-access journal PLOS Computational Biology, the research team describes how combining key physiologic measurements with a behavioral task that does not interfere with sleep onset gives a better picture of the gradual process of falling asleep.

21 Nov 2014

Kidney disease patients can benefit from simple and structured exercise

Simple yet structured exercise can significantly improve kidney disease patients' quality of life as well as decrease their pain, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

21 Nov 2014

Sanofi, Genzyme announce FDA approval of Lemtrada for treatment of relapsing forms of MS

Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.

17 Nov 2014

Sleep disorders increase risk of motor vehicle accidents, poor health status among firefighters

Sleep disorders are independent risk factors for heart attacks and motor vehicle crashes, which are the two leading causes of death for firefighters in the United States.

14 Nov 2014

Two new oral medications post-transplant is safe, beneficial for patients with hepatitis C

All patients with hepatitis C who receive a liver transplant will eventually infect their new livers. These transplanted organs then require anti-viral treatment before they become severely damaged. But traditional post-transplant hepatitis C therapy can take up to a year, is potentially toxic and can lead to organ rejection.

11 Nov 2014

Eight organizations to receive IHF grants to improve care for military veterans

Infinite Hero Foundation today announced that eight organizations will receive charitable grants to fund therapies that address the most critical mental and physical challenges facing returning military veterans and their families.

6 Nov 2014

Latest findings on Chiari malformation to be presented at Akron conference

Researchers from around the country will gather Friday and Saturday at The University of Akron to share the latest findings on Chiari malformation, a neurological disorder at the bottom of the brain that causes at least 300,000 Americans to endure head and neck pain, loss of fine motor control and many other symptoms.

6 Nov 2014

Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery

Insomnia is a "prevalent and persistent" problem for patients in the early phases of recovery from the disease of addiction—and may lead to an increased risk of relapse, according to a report in the November/December Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

6 Nov 2014

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.

4 Nov 2014

Insomnia contributes to deaths caused by motor vehicle crashes, other fatal injuries

New research suggests that insomnia is a major contributor to deaths caused by motor vehicle crashes and other unintentional fatal injuries. The results underscore the importance of the "Sleep Well, Be Well" campaign of the National Healthy Sleep Awareness Project.

31 Oct 2014

$Adults with eczema at greater risk of accidental bone fractures, other injuries$

Adults with eczema at greater risk of accidental bone fractures, other injuries

Intense itching and dry, irritable skin aren't the only problems adults with eczema face. They are at greater risk of accidental bone fractures and other injuries, a new Northwestern Medicine® study has found.

31 Oct 2014

Sleep problems very common among young children receiving treatment for psychiatric disorders

John Boekamp, Ph.D., clinical director of the Pediatric Partial Hospital Program at Bradley Hospital recently led a study that found sleep difficulties - particularly problems with falling asleep - were very common among toddlers and preschool-aged children who were receiving clinical treatment for a wide range of psychiatric disorders.

27 Oct 2014

Bad sleep quality may trigger insomnia in older adults

Reports of insomnia are common among the elderly, but a new study finds that sleep problems may stem from the quality of rest and other health concerns more than the overall amount of sleep that patients get.

9 Oct 2014

Energy drinks increase frequency of insomnia, nervousness in athletes

A study analysing the positive and negative effects of energy drinks on athletes has seen that, although in principle their sports performance was seen to improve by between 3% and 7%, there was also an increase in the frequency of insomnia, nervousness and the level of stimulation in the hours following competition.

3 Oct 2014

Researchers reveal that drug-food interactions may endanger mountaineer’s health

University of the Basque Country researchers have studied the nutritional and health situations existing at high altitudes as well as the routinely used nutritional ergogenic and pharmacological aids. According to their study, the possible interactions between drugs and food and nutrients taken may endanger the mountaineer’s health if all this is not conducted under strict control.

3 Oct 2014

UC Davis research highlights need for better guidance for primary care providers

Short questionnaires used to identify patients at risk for depression are linked with antidepressant medications being prescribed when they may not be needed, according to new research from UC Davis Health System published in the September-October issue of the Journal of the American Board of Family Medicine.

30 Sep 2014

Research points to remote monitoring as offering way to improve patient care

An aging population and an increased incidence of debilitating illnesses such as Parkinson's and Alzheimer's disease means there is pressure on technology to offer assistance with healthcare - monitoring and treatment. Research published in the International Journal of Ad Hoc and Ubiquitous Computing points to remote monitoring as offering a way to improve patient care and even accelerate medical research.

29 Sep 2014

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Lack of sleep can make you sick. And while everybody has the occasional restless night, for those who suffer from chronic insomnia — some 15 percent of older adults in the United States — that sleep loss can increase the risk for cardiovascular disease, hypertension, weight gain, type 2 diabetes, and even lead to an earlier death.

18 Sep 2014

Insomnia News and Research

Latest Insomnia News and Research

Orexo announces positive results from ISTART/006 study

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

MGH investigators develop system to accurately track the process of falling asleep

Kidney disease patients can benefit from simple and structured exercise

Sanofi, Genzyme announce FDA approval of Lemtrada for treatment of relapsing forms of MS

Sleep disorders increase risk of motor vehicle accidents, poor health status among firefighters

Two new oral medications post-transplant is safe, beneficial for patients with hepatitis C

Eight organizations to receive IHF grants to improve care for military veterans

Latest findings on Chiari malformation to be presented at Akron conference

Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Insomnia contributes to deaths caused by motor vehicle crashes, other fatal injuries

Adults with eczema at greater risk of accidental bone fractures, other injuries

Sleep problems very common among young children receiving treatment for psychiatric disorders

Bad sleep quality may trigger insomnia in older adults

Energy drinks increase frequency of insomnia, nervousness in athletes

Researchers reveal that drug-food interactions may endanger mountaineer’s health

UC Davis research highlights need for better guidance for primary care providers

Research points to remote monitoring as offering way to improve patient care

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Insomnia News and Research

Latest Insomnia News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in